Now booking for Ontario residents
Medically supervised
weight management
consultations.
Speak with a licensed Ontario healthcare provider about whether a GLP-1 medication may be appropriate as part of a personalized weight management plan. All prescribing decisions are made solely at a provider’s clinical discretion.
Secure online assessment · No obligation
- Licensed Ontario providers
- Secure virtual consultation
- Individualized care plans
- Ongoing provider follow-up
About the medication
A Clinically Guided
category of treatment.
GLP-1 receptor agonists, including semaglutide, are prescription medications. In Canada, Ozempic® (semaglutide) is approved by Health Canada for the management of Type 2 diabetes. A separate brand of semaglutide, Wegovy®, is the formulation approved for chronic weight management.
Whether any GLP-1 therapy is appropriate for you is a decision made between you and a licensed provider after a full clinical assessment.
- Provider-led care and personalized treatment planning
- Once-weekly dosing format, administered as directed by your provider
- Prescription eligibility determined solely by a licensed clinician
- Regular monitoring and check-ins throughout treatment
- Initial consultation can be completed online from anywhere in Ontario
Drug class
GLP-1 agonist
Semaglutide is a synthetic analogue of the natural GLP-1 hormone.
Administration
Subcutaneous
Once-weekly injection via a pre-filled pen device, as directed.
Access
Prescription only
Issued only after a full medical assessment by a licensed provider.
Supervision
Ongoing
Provider check-ins and monitoring continue throughout treatment.
Your Journey
How the consultation process works.
A clear, guided path from your first question to ongoing care.
Every step is led by licensed healthcare professionals.
Every step is led by licensed healthcare professionals.
01
Complete a confidential health intake
Fill out a secure questionnaire covering medical history, current health, and your goals.
02
Consult with a licensed provider
A qualified provider reviews your intake and meets with you to discuss whether treatment may be appropriate.
03
Receive an individualized plan
If clinically appropriate, your provider develops a plan tailored to your health profile and lifestyle.
04
Continue with monitored follow-up
Prescriptions are dispensed by a licensed pharmacy partner, with scheduled provider check-ins.
Important safety information
Who may be eligible for treatment?
This page is general educational information only and is not medical advice, diagnosis, or treatment. All prescribing decisions are made solely by a licensed healthcare provider after individual clinical assessment.
In Canada, Ozempic® is Health Canada-approved for Type 2 diabetes management. A different brand of semaglutide, Wegovy®, is the formulation approved for chronic weight management. Off-label prescribing is at the sole discretion of a licensed provider.
- A thorough medical evaluation is required before any prescription can be issued.
- Treatment is not suitable for everyone, and not all applicants will be approved.
- Side effects may occur, including nausea, vomiting, and other gastrointestinal symptoms. Discuss risks with your provider.
- Patients should follow their provider's guidance on dosing, diet, and activity throughout treatment.
- Ongoing monitoring by a licensed provider is an essential component of safe care.
- Individual results will vary; weight management outcomes are not guaranteed.
Who May Be Eligible for Ozempic Treatment?
This page provides general educational information only. It is not a substitute for professional medical advice, diagnosis, or treatment. All decisions regarding Ozempic prescription are made solely by a licensed healthcare provider following individual clinical assessment.
▸Ozempic requires a thorough medical evaluation before any prescription can be issued.
▸This treatment is not suitable for everyone, and not all applicants will be approved.
▸Side effects may occur and can include nausea, vomiting, and other gastrointestinal symptoms.
▸Patients should follow their provider’s guidance on dosing, diet, and activity throughout treatment.
▸Prescription approval depends entirely on an individual provider’s clinical assessment.
▸Ongoing monitoring by a licensed provider is an essential component of safe treatment.
This page has been prepared for informational purposes. It should be reviewed by a licensed medical professional and legal/compliance team prior to final publication. Individual results will vary. Weight loss outcomes are not guaranteed.
Common Questions
Frequently Asked Questions
Honest answers to the questions we hear most often about Ozempic
prescription and our consultation process.
prescription and our consultation process.
What is semaglutide / Ozempic?
Semaglutide is a GLP-1 receptor agonist medication. In Canada, Ozempic® is the brand of semaglutide approved for Type 2 diabetes management; Wegovy® is the brand approved for chronic weight management. Both are prescription-only medications.
Can I get a prescription through an online consultation?
You can begin the process with a virtual consultation. A licensed provider will review your history and goals. A prescription is only issued if, in the provider’s clinical judgment, it is appropriate for you. Eligibility is not guaranteed.
How does a GLP-1 medication work?
GLP-1 receptor agonists mimic a natural hormone that helps regulate appetite and blood sugar. They may slow digestion and reduce hunger signals. Your provider can explain how this may apply to your individual situation.
Who qualifies for treatment?
Eligibility is determined solely by a licensed healthcare provider following a full consultation. Factors considered may include BMI, health history, current medications, and weight-related health conditions. Not everyone will qualify.
How long does the consultation take?
Most virtual consultations can be completed within a standard appointment window. After your assessment, your provider will outline next steps and, if appropriate, an individualized plan.
Will I need ongoing follow-up care?
Yes. Ongoing monitoring is an essential part of any GLP-1 treatment plan. Your provider schedules follow-up check-ins, adjusts dosing where appropriate, and supports your overall health throughout treatment.
Are virtual consultations secure and confidential?
Yes. Consultations are conducted through secure channels in compliance with applicable Ontario and Canadian healthcare privacy standards (PHIPA / PIPEDA). Your information is handled with strict confidentiality.
- © 2025 Intrepid Health Group. All rights reserved.
Medical disclaimer. This website is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Ozempic® and Wegovy® are prescription medications and are registered trademarks of their respective owners. All prescribing decisions are made solely by a licensed healthcare provider following an individual clinical assessment. Eligibility is not guaranteed. Individual results vary; weight management outcomes are not guaranteed. Side effects may occur and should be discussed with your provider. This page is provided for educational purposes and is not an offer to sell, advertise, or promote a specific prescription medication. In Canada, advertising of prescription medications is regulated by Health Canada under the Food and Drugs Act.